Back to results
US 2014/0275239 A1Published application
Dronedarone Formulation
OwnerThomas D. Reynolds, Boyong Liinventors
Life of this patent
Estimating the term…
Abstract
Dronedarone formulations. Formulations of dronedarone are disclosed that provide consistent release and absorption of dronedarone that is independent of food ingestion. The disclosed formulation achieves this result through the inclusion of rate-controlling polymers, such as cellulose derivatives, acrylic polymers, and natural polymers. The dosage form may be prepared through blending, dry granulation, or wet granulation, followed by compression into a tablet.
Claims11
A dosage form that provides for the consistent release of dronedarone, comprising:
- dronedarone or a pharmaceutically acceptable salt thereof;
- a diluent;
- and
- a rate-controlling polymer.
1 more element
A method for formulating a dosage form, comprising the steps of:
- combining a diluent and a controlled-release polymer into a homogenous mixture;
- incorporating dronedarone into said homogenous mixture;
- and
- compressing said homogenous mixture into tablets.
1 more element
Dependencies are inferred from the claim text.